A person who travelled from London to Sweden to celebrate Christmas has been confirmed sick with the new and more infectious variant of the coronavirus that has been rapidly spreading in the UK recently.
Sara Byfors of Sweden's Public Health Agency told a news conference on Saturday that the person has been self-isolating since arriving in the southwestern province of Sormland and that no one else in the household has tested positive for Covid-19. However, Byfors added that there are likely more cases in Sweden that have yet to be detected, Xinhua news agency reported.
The person started feeling ill after arriving in Sweden, testing positive for Covid-19 on December 21 after experiencing extreme fatigue and body ache. On Saturday, it was confirmed that the person was infected with the mutated strain of the coronavirus.
Byfors said that the Public Health Agency has increased its efforts to monitor the new coronavirus strain and is now aiming to collect tests from everyone who has arrived in Sweden from the UK since October.
"On Monday, we issued a new recommendation urging everyone who has been in the UK to get tested so that we can conduct contact tracing and ensure this virus strain does not spread in Sweden. Those who do not show any symptoms should also get tested," said Byfors.
The Public Health Agency has also urged anyone who has travelled to Sweden from the UK and those in their households to self-isolate.
Asked how Sweden's vaccination program would be affected by a potential spread of the new coronavirus strain in the country, Byfors said it would likely not have a significant impact. However, Sweden's healthcare system is already under great strain, with 536 out of 684 ICU beds with respirators already occupied, newspaper Aftonbladet reported on Saturday.
The Agency's latest figures released on December 23 showed that a total 8,279 people have died in Sweden since the start of the pandemic, and the country has confirmed 396,048 cases. The figures are expected to go up when they are updated on December 29.
According to the website of the World Health Organization, as of December 22, there were 233 Covid-19 candidate vaccines being developed worldwide, and 61 of them were in clinical trials.
A couple of vaccines developed by pharmaceutical companies from the United States, Germany, Russia and China have so far been authorized by several countries and regions for emergency use.
--IANS
int/
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)